| 臺大學術典藏 |
2020-09-30T08:49:13Z |
Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease
|
YEN-WEN WU; Ho S.K.; Tseng W.-K.; Yeh H.-I.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. |
| 臺大學術典藏 |
2020-09-30T08:49:13Z |
2020 consensus of taiwan society of cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Li Y.-H.; Liu P.-Y.; Chang K.-C.; Shyu K.-G.; Huang J.-L.; Tsai C.-D.; Hung H.-F.; Liu M.-E.; Chao T.-F.; Cheng S.-M.; Cheng H.-M.; Chu P.-H.; Yin W.-H.; YEN-WEN WU; Chen W.-J.; Lai W.-T.; Lin S.-J.; Yeh S.-J.; Hwang J.-J.; Chiang C.-E.; Ueng K.-C.; Chao T.-H.; Lin T.-H.; Wu Y.-J.; Wang K.-L.; Sung S.-H.; Yeh H.-I. |
| 臺大學術典藏 |
2020-09-15T05:23:51Z |
Prescription patterns of anti-diabetic medications and clinical outcomes in Asian patients with heart failure and diabetes mellitus
|
Loh S.Y.; Reyes E.; Ching M.E.; Khoo D.Z.L.; Yew M.S.; Huang W.; Leong K.T.G.; See J.H.J.; Lim Y.B.; Tan S.; Yeo C.; Chai S.C.; Siswanto B.B.; Jaufeerally F.R.; KUO-LIONG CHIEN; Lee E.M.; Yeo P.S.D.; Poh K.K.; Chai P.; Wong C.C.R.; Santos J.; Yew K.L.; Narasimhan C.; Zhudi A.S.B.M.; Sari N.A.M.; Sridhar G.S.; Zuhdi A.S.M.; Ismail M.D.; Ong T.K.; Cham Y.L.; Khiew N.Z.; Said A.B.; Fong A.Y.Y.; Ngarmukos T.; Amin N.H.M.; Seng K.C.; Tan S.K.; Chan L.L.H.; Teo L.L.Y.; Lapitan R.; Andal R.; Lopez E.; Sim K.L.D.; Park S.W.; Tan B.Y.; Lim C.P.; Lim A.; Noda T.; Nakajima I.; Lam C.S.P.; Wada M.; Ishibashi K.; Kurita T.; Yasuoka R.; Asai K.; Murai K.; Kubota Y.; Izumi Y.; Ikeda T.; Hisatake S.; Uhm J.-S.; Kabuki T.; Kiuchi S.; Abidin I.Z.; Azmee M.G.; Omar R.; Ghazi A.M.; Khelae S.K.; Chew D.S.P.; Yap L.B.; Hussin A.; Muhammad Z.; Wong C.K.; Liew H.B.; Arbain A.N.; Tan Y.Z.; Mojolou R.A.; Asnawi M.H.M.; Augustine A.-A.; Naik A.; Kaur D.; Sridevi C.; Raghu K.; Gopi A.; Sastry B.K.S.; Yu C.M.; Jin Q.; Ling T.; Li X.; Seo H.S.; Zhou F.; Zhou Y.; Xu D.; Zhang H.; Su Y.; Chen X.; Qin S.; Wang J.; Gong X.; Wu Z.; Oh D.J.; Surarso R.; Danny S.S.; Martanto E.; Joung B.; Erwinanto, Munawar M.; Pambudi J.A.; Lukito A.; Pardede I.; Thengker A.; Damay V.; Tedjokusumo P.; Purayil M.P.; Sharma M.K.; Sawhney J.; Mittal S.; Verma R.; Sethi H.J.S.; Kumar M.; Chopra V.; Kim E.J.; Tandon R.; Parikh K.; Chandarana A.; Shah U.; Park C.G.; Chag M.; Baxi H.; Gupta S.; Bhatia J.; Khakhkhar V.; Sankhla V.; Patel T.; Kapoor V.; Wander G.S.; Othman M.K.; Lee Y.W.; Yen C.H.; Hagiwara N.; Suzuki A.; Suzuki T.; Hong S.K.; Lee S.; Soo L.D.; Kim D.-H.; Shim J.; Lee M.H.; Park S.-M.; Roh S.-Y.; Cho I.-J.; Park H.-N.; Park H.-W.; Cho J.-G.; Yoon N.; Lee K.; Kim K.H.; Kim S.H.; Hung C.-L.; Saharudin S.; Beh B.C.; Laothavorn P.; Tiyanon W.; Wongcharoen W.; Wu L.; Phrommintikul A.; on behalf of the ASIAN-HF Investigators; Xie Y.; Rha S.W.; Chandavimol M.; Yingchoncharoen T.; Hsieh L.-C.; Hsu C.-H.; Lo P.-H.; Chen K.-W.; Hsiao L.-C.; Wang Y.-C.; Na J.O.; Lu C.-R.; Wu H.-P.; Chen K.; Lin Y.-N.; Chang S.-S.; Liang H.-Y.; Wu C.-H.; Lo L.-W.; Huang P.-H.; Chang S.-L.; Fan X.; Lin Y.-J.; Choi J.-I.; Leu H.-B.; Wang K.-L.; Sung S.-H.; Chao T.-F.; Yu W.-C.; Hsu C.-N.; Lin J.-W.; Kuo J.-Y.; Yen C.-H.; Hwang J.-J.; Shimizu W.; Kim Y.H.; KUO-LIONG CHIEN; Su T.-C.; Lin L.-Y.; Juang J.-M.; Lin Y.-H.; Chiang F.-T.; Lin J.-L.; Ho Y.-L.; Lee C.-M.; Lin P.-C.; Kim M.; Zhang S.; Hung C.-S.; Chang S.-N.; Chia Y.M.F.; Teng T.-H.K.; Tay W.T.; Anand I.; MacDonald M.R.; Yap J.; Chandramouli C.; Richards A.M.; Tromp J.; Ouwerkerk W.; Ling L.H.; Tulsidas H.; Aung T.; Ong H.Y.; Ling L.F.; Soon D.K.N.; Yeh H.-I. |
| 臺大學術典藏 |
2020-06-01T09:06:40Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H.;Ueng K.-C.;Jeng J.-S.;Charng M.-J.;Lin T.-H.;Chien K.-L.;Chih-Yuan Wang;Chao T.-H.;Liu P.-Y.;Su C.-H.;Chien S.-C.;Liou C.-W.;Tang S.-C.;Lee C.-C.;Yu T.-Y.;Chen J.-W.;Wu C.-C.;Yeh H.-I.;The Writing Group Of 2017 Taiwan Lipid Guidelines For High Risk Patients; Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; CHIH-YUAN WANG; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Yeh H.-I.; Wu C.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-05T08:37:33Z |
The relationship among carotid artery remodeling, cardiac geometry, and serum N-terminal Pro-B-Type natriuretic peptide level in asymptomatic Asians: Sex-differences and longitudinal GEE study
|
Chien C.-Y.;Liu C.-C.;Po H.L.;Yen C.-H.;Hou C.J.-Y.;Kuo J.-Y.;Hung C.-L.;Shoei-Shen Wang;Yeh H.-I.;Lam C.S.P.; Chien C.-Y.; Liu C.-C.; Po H.L.; Yen C.-H.; Hou C.J.-Y.; Kuo J.-Y.; Hung C.-L.; SHOEI-SHEN WANG; Yeh H.-I.; Lam C.S.P. |
| 臺大學術典藏 |
2020-03-05T06:05:29Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; Wu C.-C.; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; LI-KAI TSAI; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L. |
| 臺大學術典藏 |
2020-03-04T09:03:24Z |
Downregulated myocardial connexin 43 and suppressed contractility in rabbits subjected to a cholesterol-enriched diet
|
Lin L.-C.;Chau-Chung Wu;Yeh H.-I.;Lu L.-S.;Liu Y.-B.;Lin S.-F.;Lee Y.-T.; Lin L.-C.; CHAU-CHUNG WU; Yeh H.-I.; Lu L.-S.; Liu Y.-B.; Lin S.-F.; Lee Y.-T. |
| 臺大學術典藏 |
2020-03-04T09:03:19Z |
Biofunctionalized magnetic nanoparticles for in vitro labeling and in vivo locating specific biomolecules
|
Tsai M.C.; Gao Y.L.; Wang W.C.; Hung S.W.; Yang S.Y.; Horng H.E.; Yang H.C.; Tseng W.Y.I.; Yeh H.I.; Hsuan C.F.; Lee T.L.; Tseng W.K.; Liu Y.B.; Huang H.C.; Yang Y.F.; Lin L.C.; Lin L.Y.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2020-03-04T09:03:11Z |
Gender difference in statin intervention on blood lipid control among patients with coronary heart disease
|
Chen C.-Y.;Chuang S.-Y.;Fang C.-C.;Huang L.-C.;Hsieh I.-C.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Chen C.-Y.; Chuang S.-Y.; Fang C.-C.; Huang L.-C.; Hsieh I.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:10Z |
Gender disparities in optimal lipid control among patients with coronary artery disease
|
Chen C.-Y.;Chuang S.-Y.;Fang C.-C.;Huang L.-C.;Hsieh I.-C.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Chen C.-Y.; Chuang S.-Y.; Fang C.-C.; Huang L.-C.; Hsieh I.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:09Z |
The impact of chronic kidney disease on lipid management and goal attainment in patients with atherosclerosis diseases in Taiwan
|
Lin T.-H.;Chuang S.-Y.;Chu C.-Y.;Lee W.-H.;Hsu P.-C.;Su H.-M.;Li Y.-H.;Fang C.-C.;Wang K.-Y.;Tseng W.-K.;Li A.-H.;Ueng K.-C.;Hsieh I.-C.;Huang L.-C.;Wang C.-H.;Pan W.-H.;Yeh H.-I.;Chau-Chung Wu;Yin W.-H.;Chen J.-W.; Lin T.-H.; Chuang S.-Y.; Chu C.-Y.; Lee W.-H.; Hsu P.-C.; Su H.-M.; Li Y.-H.; Fang C.-C.; Wang K.-Y.; Tseng W.-K.; Li A.-H.; Ueng K.-C.; Hsieh I.-C.; Huang L.-C.; Wang C.-H.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Yin W.-H.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:08Z |
Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan
|
Ho L.-T.; Yin W.-H.; Chuang S.-Y.; Tseng W.-K.; Wu Y.-W.; Hsieh I.-C.; Lin T.-H.; Li Y.-H.; Huang L.-C.; Wang K.-Y.; Ueng K.-C.; Fang C.-C.; Pan W.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:07Z |
Combination with low-dose dextromethorphan improves the effect of amlodipine monotherapy in clinical hypertension a first-in-human, concept-proven, prospective, dose-escalation, multicenter study
|
Yin W.-H.; Chen P.; Yeh H.-I.; Wang K.-Y.; Hung Y.-J.; Tseng W.-K.; Wen M.-S.; Wu T.-C.; CHAU-CHUNG WU; Cheng S.-M.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:07Z |
Guideline-adherent therapy in patients with cardiovascular diseases in Taiwan
|
Jeng J.-S.; Yin W.-H.; Huang C.-C.; Chuang S.-Y.; Yeh H.-I.; Fang C.-C.; Lin T.-H.; Wang K.-Y.; Tseng W.-K.; Huang L.-C.; Ueng K.-C.; Hsieh I.-C.; Li Y.-H.; Pan W.-H.; CHAU-CHUNG WU; Chen J.-W.; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:06Z |
2017 Taiwan lipid guidelines for high risk patients
|
Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; CHAU-CHUNG WU; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-04T09:03:06Z |
Identification of new biosignatures for clinical outcomes in stable coronary artery disease - The study protocol and initial observations of a prospective follow-up study in Taiwan
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Optimal achieved blood pressure for patients with stable coronary artery disease
|
Huang C.-C.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh Y.-T.; Yin W.-H.; Tseng W.-K.; Lin F.-J.; Yeh H.-I.; Chen J.-W.; Wu Y.-W.; CHAU-CHUNG WU; Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:05Z |
Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease
|
Chien S.-C.; Chen C.-Y.; Leu H.-B.; Su C.-H.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Yeh H.-I.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:04Z |
Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus
|
Lin F.-J.;Tseng W.-K.;Yin W.-H.;Yeh H.-I.;Chen J.-W.;Chau-Chung Wu; Lin F.-J.; Tseng W.-K.; Yin W.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease
|
Ho S.-K.; Wu Y.-W.; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
Erratum: ‘Corrigendum to “2017 Taiwan lipid guidelines for high risk patients” [Journal of the Formosan Medical Association (2017) [217–248]’(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H.; Ueng K.-C.; Jeng J.-S.; Charng M.-J.; Lin T.-H.; Chien K.-L.; Wang C.-Y.; Chao T.-H.; Liu P.-Y.; Su C.-H.; Chien S.-C.; Liou C.-W.; Tang S.-C.; Lee C.-C.; Yu T.-Y.; Chen J.-W.; CHAU-CHUNG WU; Yeh H.-I.; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-04T09:03:03Z |
On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study
|
Ho L.-T.; Lin F.-J.; Tseng W.-K.; Yin W.-H.; Wu Y.-W.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Li Y.-H.;Chen J.-W.;Lin T.-H.;Wang Y.-C.;Chau-Chung Wu;Yeh H.-I.;Huang C.-C.;Chang K.-C.;Wu C.-K.;Chen P.-W.;Huang C.-W.;Chen Z.-C.;Chang W.-T.;Huang W.-C.;Wang C.-Y.;Lee M.-Y.;Chao A.-C.;Fu W.-R.;Tsai L.-K.;Tang S.-C.;Chan H.-L.;Yang Y.-C.;Wu Y.-W.;Hwang J.-J.;Lin J.-L.; Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; CHAU-CHUNG WU; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L. |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
Circulating TNFSF14 (Tumor Necrosis Factor Superfamily 14) Predicts Clinical Outcome in Patients with Stable Coronary Artery Disease
|
Hsu C.-Y.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Chang K.-C.;Wang J.-H.;Chou R.-H.;Huang C.-Y.;Huang P.-H.;Leu H.-B.;Yin W.-H.;Chau-Chung Wu;Lin S.-J.;Chen J.-W.; Hsu C.-Y.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Chou R.-H.; Huang C.-Y.; Huang P.-H.; Leu H.-B.; Yin W.-H.; CHAU-CHUNG WU; Lin S.-J.; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T09:03:02Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai H.-S.; Tseng W.-K.; Yin W.-H.; Lin F.-J.; Hsuan C.-F.; Wu Y.-W.; Huang L.-C.; Lin T.-H.; Chang K.-C.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU |
| 臺大學術典藏 |
2020-03-04T09:03:00Z |
The benefit of secondary prevention with oat fiber in reducing future cardiovascular event among CAD patients after coronary intervention
|
Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU; Chen J.-W.; Wu J.-R.;Leu H.-B.;Yin W.-H.;Tseng W.-K.;Wu Y.-W.;Lin T.-H.;Yeh H.-I.;Chang K.-C.;Wang J.-H.;Chau-Chung Wu;Chen J.-W.; Wu J.-R. |
| 臺大學術典藏 |
2020-03-04T09:03:00Z |
Author Correction: The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease (Scientific Reports, (2018), 8, 1, (14410), 10.1038/s41598-018-32210-x)
|
Ho S.-K.; Wu Y.-W.; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2020-03-04T05:42:45Z |
2017 Taiwan lipid guidelines for high risk patients
|
The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients; Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I |
| 臺大學術典藏 |
2020-03-04T05:42:38Z |
Erratum: ��Corrigendum to ��2017 Taiwan lipid guidelines for high risk patients�� [Journal of the Formosan Medical Association (2017) [217�V248]��(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-04T05:42:36Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Huang C.-C; Chang K.-C; Wu C.-K; Chen P.-W; Huang C.-W; Chen Z.-C; Chang W.-T; Huang W.-C; Wang C.-Y; Lee M.-Y; Chao A.-C; Fu W.-R; Tsai L.-K; SUNG-CHUN TANG; Chan H.-L; Yang Y.-C; Wu Y.-W; Hwang J.-J; Lin J.-L.; Li Y.-H; Chen J.-W; Lin T.-H; Wang Y.-C; Wu C.-C; Yeh H.-I |
| 臺大學術典藏 |
2020-03-04T05:42:32Z |
2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance
|
Chien S.-C; Chen P.-S; Huang Y.-H; SUNG-CHUN TANG; Li Y.-H; Yeh H.-I. |
| 臺大學術典藏 |
2020-03-03T03:06:50Z |
Biofunctionalized magnetic nanoparticles for in vitro labeling and in vivo locating specific biomolecules
|
Wu C.C.; Lin L.Y.; Lin L.C.; Huang H.C.; Yang Y.F.; Liu Y.B.; Tsai M.C.; Gao Y.L.; Wang W.C.; Hung S.W.; Yang S.Y.; Horng H.E.; Yang H.C.; WEN-YIH TSENG; Yeh H.I.; Hsuan C.F.; Lee T.L.; Tseng W.K. |
| 臺大學術典藏 |
2020-03-02T12:10:57Z |
2017 Taiwan lipid guidelines for high risk patients
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-02T12:10:46Z |
Erratum: ��Corrigendum to ��2017 Taiwan lipid guidelines for high risk patients�� [Journal of the Formosan Medical Association (2017) [217�V248]��(S0929664616304302)(10.1016/j.jfma.2016.11.013)
|
Li Y.-H; Ueng K.-C; Jeng J.-S; Charng M.-J; Lin T.-H; Chien K.-L; Wang C.-Y; Chao T.-H; Liu P.-Y; Su C.-H; Chien S.-C; Liou C.-W; SUNG-CHUN TANG; Lee C.-C; Yu T.-Y; Chen J.-W; Wu C.-C; Yeh H.-I; The Writing Group of 2017 Taiwan Lipid Guidelines for High Risk Patients |
| 臺大學術典藏 |
2020-03-02T12:10:43Z |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
SUNG-CHUN TANG;Lin J.-L.;Hwang J.-J;Wu Y.-W;Yang Y.-C;Chan H.-L;Tsai L.-K;Fu W.-R;Chao A.-C;Lee M.-Y;Wang C.-Y;Huang W.-C;Chang W.-T;Chen Z.-C;Huang C.-W;Chen P.-W;Wu C.-K;Chang K.-C;Huang C.-C;Yeh H.-I;Wu C.-C;Wang Y.-C;Lin T.-H;Chen J.-W;Li Y.-H; Li Y.-H; Chen J.-W; Lin T.-H; Wang Y.-C; Wu C.-C; Yeh H.-I; Huang C.-C; Chang K.-C; Wu C.-K; Chen P.-W; Huang C.-W; Chen Z.-C; Chang W.-T; Huang W.-C; Wang C.-Y; Lee M.-Y; Chao A.-C; Fu W.-R; Tsai L.-K; SUNG-CHUN TANG; Chan H.-L; Yang Y.-C; Wu Y.-W; Hwang J.-J; Lin J.-L. |
| 臺大學術典藏 |
2020-03-02T12:10:30Z |
2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance
|
SUNG-CHUN TANG;Yeh H.-I.;Li Y.-H;Huang Y.-H;Chen P.-S;Chien S.-C; Chien S.-C; Chen P.-S; Huang Y.-H; SUNG-CHUN TANG; Li Y.-H; Yeh H.-I. |
| 臺大學術典藏 |
2020-02-27T07:42:46Z |
2015 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension
|
Chiang C.-E.; Wang T.-D.; Ueng K.-C.; Lin T.-H.; Yeh H.-I.; Chen C.-Y.; Wu Y.-J.; Tsai W.-C.; Chao T.-H.; Chen C.-H.; Chu P.-H.; Chao C.-L.; Liu P.-Y.; Sung S.-H.; Cheng H.-M.; Wang K.-L.; Li Y.-H.; Chiang F.-T.; Chen J.-H.; WEN-JONE CHEN; Yeh S.-J.; Lin S.-J.; Lin S.-J.;Yeh S.-J.;WEN-JONE CHEN;Chen J.-H.;Chiang F.-T.;Li Y.-H.;Wang K.-L.;Cheng H.-M.;Sung S.-H.;Liu P.-Y.;Chao C.-L.;Chu P.-H.;Chen C.-H.;Chao T.-H.;Tsai W.-C.;Wu Y.-J.;Chen C.-Y.;Yeh H.-I.;Lin T.-H.;Ueng K.-C.;Wang T.-D.;Chiang C.-E. |
| 臺大學術典藏 |
2020-02-27T07:42:37Z |
The 2017 focused update of the guidelines of the Taiwan society of cardiology (TSOC) and the Taiwan hypertension society (THS) for the management of hypertension
|
Lin J.-L.; Lin J.-L.;Lin S.-J.;Chen M.-F.;Yeh S.-J.;WEN-JONE CHEN;Chen J.-H.;Lai W.-T.;Chiang F.-T.;Wang K.-Y.;Li Y.-H.;Wang K.-L.;Sung S.-H.;Chu P.-H.;Chen C.-Y.;Ueng K.-C.;Shyu K.-G.;Chen C.-H.;Chao T.-H.;Cheng H.-M.;Liu P.-Y.;Yeh H.-I.;Lin T.-H.;Wang T.-D.;Chiang C.-E.; Chiang C.-E.; Wang T.-D.; Lin T.-H.; Yeh H.-I.; Liu P.-Y.; Cheng H.-M.; Chao T.-H.; Chen C.-H.; Shyu K.-G.; Ueng K.-C.; Chen C.-Y.; Chu P.-H.; Sung S.-H.; Wang K.-L.; Li Y.-H.; Wang K.-Y.; Chiang F.-T.; Lai W.-T.; Chen J.-H.; WEN-JONE CHEN; Yeh S.-J.; Chen M.-F.; Lin S.-J. |
| 臺大學術典藏 |
2020-02-25T09:38:31Z |
The correlation between waist-hip ratio and achieving therapeutic lipid goals in Taiwan
|
Tsai, H.-S.;Tseng, W.-K.;Yin, W.-H.;Fang-Ju Lin;Hsuan, C.-F.;Wu, Y.-W.;Huang, L.-C.;Lin, T.-H.;Chang, K.-C.;Li, Y.-H.;Yeh, H.-I.;Chen, J.-W.;Wu, C.-C.; Tsai, H.-S.; Tseng, W.-K.; Yin, W.-H.; FANG-JU LIN; Hsuan, C.-F.; Wu, Y.-W.; Huang, L.-C.; Lin, T.-H.; Chang, K.-C.; Li, Y.-H.; Yeh, H.-I.; Chen, J.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-02-25T09:24:04Z |
Lipid lowering therapy in patients with atherosclerotic cardiovascular diseases: Which matters in the real world? Statin intensity or low-density lipoprotein cholesterol level? – Data from a multicenter registry cohort study in Taiwan
|
Yeh, Y.-T.; Yin, W.-H.; Tseng, W.-K.; FANG-JU LIN; Yeh, H.-I.; Chen, J.-W.; Wu, Y.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-02-25T09:10:00Z |
Residual risk factors to predict major adverse cardiovascular events in atherosclerotic cardiovascular disease patients with and without diabetes mellitus
|
FANG-JU LIN; Tseng, W.-K.; Yin, W.-H.; Yeh, H.-I.; Chen, J.-W.; Wu, C.-C. |
| 臺大學術典藏 |
2020-01-13T08:21:29Z |
Dose-related ethanol intake, Cx43 and Nav1.5 remodeling: Exploring insights of altered ventricular conduction and QRS fragmentation in excessive alcohol users
|
Hung, C.-L.; Lai, Y.-J.; Chi, P.-C.; Chen, L.-C.; Tseng, Y.-M.; Kuo, J.-Y.; Lin, C.-I.; Chen, Y.-C.; Lin, S.-J.; Yeh, H.-I.; LIANG-CHIA CHEN |
| 臺大學術典藏 |
2020-01-13T08:21:28Z |
Corrigendum to “Dose-related ethanol intake, Cx43 and Nav1.5 remodeling: Exploring insights of altered ventricular conduction and QRS fragmentation in excessive alcohol users” [J. Mol. Cell. Cardiol. 114 (2018) 150–160](S0022282817303358)(10.1016/j.yjmcc.2017.10.011)
|
Hung, C.-L.; Lai, Y.-J.; Chi, P.-C.; Chen, L.-C.; Tseng, Y.-M.; Kuo, J.-Y.; Lin, C.-I.; Chen, Y.-C.; Lin, S.-J.; Yeh, H.-I.; LIANG-CHIA CHEN |
| 臺大學術典藏 |
2020 |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; CHIH-YUAN WANG; Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L.; Chang K.-C.; Huang C.-C.; Yeh H.-I.; Wu C.-C.; Lin T.-H.; Wang Y.-C.; Chen J.-W.; Li Y.-H.; Li Y.-H.;Chen J.-W.;Lin T.-H.;Wang Y.-C.;Wu C.-C.;Yeh H.-I.;Huang C.-C.;Chang K.-C.;Wu C.-K.;Chen P.-W.;Huang C.-W.;Chen Z.-C.;Chang W.-T.;Huang W.-C.;Chih-Yuan Wang;Lee M.-Y.;Chao A.-C.;Fu W.-R.;Tsai L.-K.;Tang S.-C.;Chan H.-L.;Yang Y.-C.;Wu Y.-W.;Hwang J.-J.;Lin J.-L. |
| 臺大學術典藏 |
2020 |
Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70–100 mg/dL in Taiwan
|
FANG-JU LIN; Shyu K.-G.; Hsieh I.-C.; Huey-Herng Sheu W.; Tu S.-T.; Yeh S.-J.; Chen C.-I.; Lu K.-C.; Wu C.-C.; Shau W.-Y.; Inocencio T.J.; Wen Y.-C.; Yeh H.-I. |
| 國立成功大學 |
2020 |
2020 consensus of taiwan society of cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases
|
Chiang, Chiang C.-E.;Ueng, K.-C.;Chao, T.-H.;Lin, T.-H.;Wu, Y.-J.;Wang, K.-L.;Sung, Sung S.-H.;Yeh, H.-I.;Li, Y.-H.;Liu, P.-Y.;Chang, K.-C.;Shyu, K.-G.;Huang, J.-L.;Tsai, C.-D.;Hung, Hung H.-F.;Liu, M.-E.;Chao, T.-F.;Cheng, S.-M.;Cheng, H.-M.;Chu, P.-H.;Yin, W.-H.;Wu, Y.-W.;Chen, W.-J.;Lai, W.-T.;Lin, S.-J.;Yeh, S.-J.;Hwang, J.-J. |
| 國立成功大學 |
2020 |
Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment
|
Li, Y.-H.;Tseng, W.-K.;Yin, W.-H.;Lin, F.-J.;Wu, Y.-W.;Hsieh, I.-C.;Lin, T.-H.;Sheu, W.H.-H.;Yeh, H.-I.;Chen, J.-W.;Wu, C.-C.;Investigators, Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry |
| 國立成功大學 |
2020 |
A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan
|
Li, Y.-H.;Chen, J.-W.;Lin, T.-H.;Wang, Y.-C.;Wu, C.-C.;Yeh, H.-I.;Huang, C.-C.;Chang, K.-C.;Wu, C.-K.;Chen, P.-W.;Huang, C.-W.;Chen, Z.-C.;Chang, W.-T.;Huang, W.-C.;Wang, C.-Y.;Lee, M.-Y.;Chao, A.-C.;Fu, W.-R.;Tsai, L.-K.;Tang, S.-C.;Chan, H.-L.;Yang, Yang Y.-C.;Wu, Y.-W.;Hwang, J.-J.;Lin, J.-L. |
| 臺大學術典藏 |
2019-08-27T07:33:21Z |
Membrane proteomics of impaired energetics and cytoskeletal disorganization in elderly diet-induced diabetic mice
|
Lam, C.S.P.;Lee, H.-C.;Liu, C.-Y.;Yeh, H.-I.;Chiau, J.-S.C.;Lai, Y.-J.;Shih, S.-C.;Su, C.-H.;Hsu, Y.-L.;Chang, C.-W.;Han, C.-L.;SZU-HUA PAN;Hung, C.-L.; Hung, C.-L.; SZU-HUA PAN; Han, C.-L.; Chang, C.-W.; Hsu, Y.-L.; Su, C.-H.; Shih, S.-C.; Lai, Y.-J.; Chiau, J.-S.C.; Yeh, H.-I.; Liu, C.-Y.; Lee, H.-C.; Lam, C.S.P. |
